Garcia, P L
Miller, A L
Kreitzburg, K M
Council, L N
Gamblin, T L
Christein, J D
Heslin, M J
Arnoletti, J P
Richardson, J H
Chen, D
Hanna, C A
Cramer, S L
Yang, E S
Qi, J
Bradner, J E
Yoon, K J
Article History
Received: 12 January 2015
Revised: 4 March 2015
Accepted: 16 March 2015
First Online: 11 May 2015
Competing interests
: James E Bradner and DFCI founded Tensha Therapeutics to develop derivatives of JQ1 and similar molecules for cancer therapy.